Company Name:Amgen Inc.
CEO: Robert A. Bradway

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.


Key numbers

Market Capitalization:143489494160
Shares Outstanding: 594184000
Float: 592861346
Next Earning Date:2020-01-30
TTm EPS: 13.1141
TTm Dividend Rate: 5.67
200 days moving average:199.84
50 days moving average: 234.01
One day percent Change: -0.72



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,